Serious adverse events · adults with advanced cancer and cancer‐related fatigue
1 finding from 1 review
Quality of life ( · adults with advanced cancer and cancer‐related fatigue
1 finding from 1 review
Incidence of coronary artery abnormalities · children diagnosed with Kawasaki disease
Corticosteroids probably leads to lower incidence of coronary artery abnormalities compared with no corticosteroid use (moderate certainty).
1 finding from 1 review
Mortality (all‐cause) · children diagnosed with Kawasaki disease
1 finding from 1 review
Duration of clinical symptoms: fever and rash (days) · children diagnosed with Kawasaki disease
1 finding from 1 review
Time for laboratory parameters to normalise: CRP, ESR (days) Duration: N/A · children diagnosed with Kawasaki disease
1 finding from 1 review
Length of hospital stay · children diagnosed with Kawasaki disease
1 finding from 1 review
Longer term (> 1 year after disease onset) coronary morbidity (non‐aneurysmal) · children diagnosed with Kawasaki disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain resolution · patients with sore throat
Corticosteroids leads to higher complete resolution of pain at 24 hours compared with placebo (high certainty).
2 findings from 1 review
Time to initial pain relief (minutes) · patients with sore throat
1 finding from 1 review
Mean time to resolution of pain · patients with sore throat
1 finding from 1 review
Absolute reduction in pain measured by VAS · patients with sore throat
1 finding from 1 review
Adverse events · patients with sore throat
Corticosteroids showed no clear difference in adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Recurrence · patients with sore throat
Corticosteroids showed no clear difference in recurrence/relapse rates compared with placebo (moderate certainty).
1 finding from 1 review
Days missed from work or school · patients with sore throat
1 finding from 1 review
28‐Day all‐cause mortalitya · children and adults with sepsis
Corticosteroids probably leads to lower 28‐Day all‐cause mortalitya compared with placebo or usual care (moderate certainty).
1 finding from 1 review
Long‐term mortalityc · children and adults with sepsis
Corticosteroids showed no clear difference in long‐term mortalityc compared with placebo or usual care (low certainty).
1 finding from 1 review
Hospital mortality · children and adults with sepsis
Corticosteroids probably leads to lower hospital mortality compared with placebo or usual care (moderate certainty).
1 finding from 1 review
ICU length of stay (general intensive care patients) · children and adults with sepsis
1 finding from 1 review
Duration of hospital stay MCID: 1 day absolute difference · children and adults with sepsis
1 finding from 1 review